Publication: Strategic Research & Innovation Agenda

The European Technology Platform on Nanomedicine published this year together with Euromed2 the update of the Strategic Research & Innovation Agenda for Nanomedicine for 2016-2030.

This documents is intended to provide a framework for the deployment of innovative Nanomedicine solutions for healthcare and to provide public authorities, including the European Commission, with roadmap and priorities for research.

Infectious diseases and multidrug resistance resistance bacteria are still a priority.

To learn more, you can read the report here.



The NAREB project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 604237.